Cibc Asset Management Inc Guardant Health, Inc. Transaction History

Cibc Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$43.66 - $61.0 $172,849 - $241,499	3,959 New	3,959 $213,000
Q2 2022 Aug 09, 2022	SELL	$28.82 - $77.35 $122,427 - $328,582	-4,248 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$88.71 - $120.43 $14,193 - $19,268	160 Added 3.91%	4,248 $425,000
Q3 2021 Nov 09, 2021	BUY	$98.77 - $132.17 $38,619 - $51,678	391 Added 10.58%	4,088 $511,000
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $27,186 - $38,327	214 Added 6.14%	3,697 $564,000
Q3 2020 Nov 05, 2020	BUY	$80.32 - $111.8 $6,907 - $9,614	86 Added 2.53%	3,483 $389,000
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $202,087 - $281,203	3,397 New	3,397 $265,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.